Home

Martin H. Huber Jr., President, CEO: Mersana Therapeutics MRSN Sell · Filed 25/01/17

Trade details

Type
Insider sale
Amount
$2,618.12
Shares · price
4,514 sh · $0.58 a share
Held after
122,875 sh
Trade date
25/01/16
Filed
25/01/17
Days to filing
1 days

Sold 3.5% of holdings

Share of holding sold
3.5%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/17~25/02/15

Martin H. Huber Jr.'s recent trades

  • Martin H. Huber Jr.

    Sell10b5-1 planMersana Therapeutics

    $14.7K

    Filed 25/09/15

  • Martin H. Huber Jr.

    BuySyndax Pharmaceuticals

    $45K

    Filed 25/05/19

  • Martin H. Huber Jr.

    Sell10b5-1 planMersana Therapeutics

    $88.7K

    Filed 24/09/13

Martin H. Huber Jr., CEO — sold $2,618 of Mersana Therapeutics MRSN · 3.5% of holdings · 10b5-1 plan | Whalegun